Skip to main content

Abingworth LLP

SEC CIK
0001397144
Latest filing
Feb 10, 2023

Holdings in Q2 2021

Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.

Institution overview
Positions
19
+2 vs. Q1 2021
Portfolio value
$323.5M
+$34.0M (+11.7%) vs. Q1 2021
Filed
Aug 16, 2021
SEC
Holdings of Abingworth LLP in Q2 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
PCVXVaxcyte, Inc.COM4,168,718$93.6M28.9%00.0%UnchangedHistory
PHATPhathom Pharmaceuticals, Inc.COM1,203,135$40.7M12.6%00.0%UnchangedHistory
VERAVera Therapeutics, Inc.CL A2,960,231$38.5M11.9%+2,960,231NewHistory
Spruce BioE5209E109Common1,792,518$20.1M6.2%00.0%Unchanged–
SIENProject Sage Oldco, Inc.COM2,390,843$19.0M5.9%00.0%UnchangedHistory
OKUROnKure Therapeutics, Inc.COM1,962,221$18.2M5.6%+1,962,221NewHistory
SRRASierra Oncology, Inc.COM871,125$16.8M5.2%00.0%UnchangedHistory
ACETAdicet Bio, Inc.COM1,615,385$16.6M5.1%00.0%UnchangedHistory
VRNAVerona Pharma plcSPONSORED ADS2,457,499$16.0M4.9%00.0%UnchangedHistory
SLNOSoleno Therapeutics IncCOM NEW10,302,602$11.6M3.6%00.0%UnchangedHistory
XCURExicure, Inc.COM6,977,000$10.4M3.2%00.0%UnchangedHistory
NCNANuCana plcSPONSORED ADR3,333,333$9.20M2.8%00.0%UnchangedHistory
PRTKParatek Pharmaceuticals, Inc.COM1,041,131$7.09M2.2%00.0%UnchangedHistory
SYRESpyre Therapeutics, Inc.COM240,500$1.67M0.5%00.0%UnchangedHistory
MTEMMolecular Templates, Inc.COM200,000$1.56M0.5%00.0%UnchangedHistory
XFORX4 Pharmaceuticals, IncCOM229,885$1.49M0.5%00.0%UnchangedHistory
CBAYCymaBay Therapeutics, Inc.COM131,036$571.0K0.2%00.0%UnchangedHistory
OBSVObsEva SACOM87,999$266.0K0.1%00.0%UnchangedHistory
OCGNOcugen, Inc.Common7,111$57.0K<0.1%00.0%UnchangedHistory